Insulet Total Assets 2007-2019 | PODD

Insulet total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Insulet total assets for the quarter ending September 30, 2019 were $1.268B, a 43.11% increase year-over-year.
  • Insulet total assets for 2018 were $0.929B, a 13.71% increase from 2017.
  • Insulet total assets for 2017 were $0.817B, a 78.86% increase from 2016.
  • Insulet total assets for 2016 were $0.457B, a 65.98% increase from 2015.
Insulet Annual Total Assets
(Millions of US $)
2018 $929
2017 $817
2016 $457
2015 $275
2014 $297
2013 $288
2012 $198
2011 $221
2010 $156
2009 $173
2008 $108
2007 $131
2006 $57
2005 $0
Insulet Quarterly Total Assets
(Millions of US $)
Q3 2019 $1,268
Q2 2019 $978
Q1 2019 $953
Q4 2018 $929
Q3 2018 $886
Q2 2018 $839
Q1 2018 $830
Q4 2017 $817
Q3 2017 $500
Q2 2017 $459
Q1 2017 $445
Q4 2016 $457
Q3 2016 $453
Q2 2016 $263
Q1 2016 $255
Q4 2015 $275
Q3 2015 $293
Q2 2015 $300
Q1 2015 $306
Q4 2014 $297
Q3 2014 $301
Q2 2014 $325
Q1 2014 $289
Q4 2013 $288
Q3 2013 $289
Q2 2013 $286
Q1 2013 $281
Q4 2012 $198
Q3 2012 $203
Q2 2012 $204
Q1 2012 $216
Q4 2011 $221
Q3 2011 $216
Q2 2011 $226
Q1 2011 $149
Q4 2010 $156
Q3 2010 $150
Q2 2010 $162
Q1 2010 $159
Q4 2009 $173
Q3 2009 $117
Q2 2009 $99
Q1 2009 $120
Q4 2008 $108
Q3 2008 $135
Q2 2008 $155
Q1 2008 $116
Q4 2007 $131
Q3 2007 $136
Q2 2007 $149
Q1 2007 $48
Q4 2006 $57
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $12.162B $0.738B
INSULET CORPORATION is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use components with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.471B 19.56
Abbott Laboratories (ABT) United States $143.067B 25.04
Stryker (SYK) United States $77.279B 24.98
Boston Scientific (BSX) United States $55.628B 25.10
Baxter (BAX) United States $44.413B 26.93
Lonza Group Ag (LZAGY) Switzerland $31.143B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.905B 19.02
EssilorLuxottica Societe Anonyme (ESLOY) France $30.846B 0.00
Coloplast (CLPBY) Denmark $28.771B 44.40
Terumo (TRUMY) Japan $24.654B 30.77
ResMed (RMD) United States $23.979B 41.66
Smith & Nephew SNATS (SNN) United Kingdom $20.809B 0.00
Sunny Optical Technology (SNPTF) China $18.147B 0.00
Bio-Rad Laboratories (BIO) United States $11.027B 51.52
Perrigo (PRGO) Ireland $8.275B 15.43
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Canopy Growth (CGC) Canada $6.854B 0.00
Hill-Rom Holdings (HRC) United States $6.850B 19.70
Haemonetics (HAE) United States $5.540B 34.10
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.217B 27.49
Envista Holdings (NVST) United States $4.210B 0.00
NuVasive (NUVA) United States $3.698B 28.59
GW Pharmaceuticals (GWPH) United Kingdom $3.616B 0.00
Neogen (NEOG) United States $3.531B 58.76
Quidel (QDEL) United States $3.256B 28.58
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.224B 0.00
Agios Pharmaceuticals (AGIO) United States $3.200B 0.00
National Vision Holdings (EYE) United States $2.677B 60.41
Aurora Cannabis (ACB) Canada $1.765B 0.00
AtriCure (ATRC) United States $1.553B 0.00
TG Therapeutics (TGTX) United States $1.410B 0.00
Cardiovascular Systems (CSII) United States $1.363B 0.00
NanoString Technologies (NSTG) United States $1.178B 0.00
InMode (INMD) Israel $1.076B 0.00
Phibro Animal Health (PAHC) United States $1.035B 20.47
Aphria (APHA) $1.023B 0.00
PetIQ (PETQ) United States $0.925B 22.57
VAREX IMAGING (VREX) United States $0.904B 18.79
Cerus (CERS) United States $0.795B 0.00
Quanterix (QTRX) United States $0.726B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.674B 25.82
Lantheus Holdings (LNTH) United States $0.655B 14.90
Omeros (OMER) United States $0.649B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.642B 122.46
LeMaitre Vascular (LMAT) United States $0.595B 33.84
MacroGenics (MGNX) United States $0.538B 0.00
Surmodics (SRDX) United States $0.493B 56.66
Zynex (ZYXI) United States $0.416B 47.11
Owens & Minor (OMI) United States $0.414B 15.33
Organigram Holdings (OGI) Canada $0.392B 0.00
OraSure Technologies (OSUR) United States $0.373B 46.54
HEXO (HEXO) $0.358B 0.00
Utah Medical Products (UTMD) United States $0.354B 25.16
Meridian Bioscience (VIVO) United States $0.319B 12.85
BioLife Solutions (BLFS) United States $0.311B 126.75
Evolus (EOLS) United States $0.290B 0.00
Female Health (VERU) United States $0.278B 0.00
Repro-Med Systems (KRMD) United States $0.272B 172.00
Bovie Medical (APYX) United States $0.243B 0.00
InfuSystems Holdings (INFU) United States $0.208B 1046.00
Rockwell Medical (RMTI) United States $0.199B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.196B 0.00
Vapotherm (VAPO) United States $0.195B 0.00
Viemed Healthcare (VMD) United States $0.189B 19.92
Cytosorbents (CTSO) United States $0.184B 0.00
United Health Products (UEEC) United States $0.183B 0.00
Liberty Health Sciences (LHSIF) Canada $0.146B 0.00
Fonar (FONR) United States $0.129B 9.37
Chimerix (CMRX) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.121B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
United-Guardian (UG) United States $0.074B 18.77
Nephros (NEPH) United States $0.070B 0.00
Chembio Diagnostics (CEMI) United States $0.067B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Myomo (MYO) United States $0.003B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00